Not negative about the company at all-have never been

New Post Public Reply Private Reply Replies (1) Message Board
microcaps Machiavelli10 #645
Not negative about the company at all-have never been

anybody who reads my posts sees I totally believe in the co's products.

I've been trying to PROTECT/warn the company/longs about some of the games/tactics shorters use,including the very common ce slap on companies who transition to substantial revenues while still non-current otc classification.

Since so many still dont get it, Otc , sec, fbi, dtc,brokers etc are all opposed to non-current classification and have been politically charged as I've explained to eliminate non-current companies.

i find it bizarre so many are having trouble understanding after explaining it in detail and totally missing the point.

I'm trying to prevent that from happening to NNLX- which I'm told has now been informed of the ce trap -

but if even the geniuses here who have read much more about it than that which had been relayed to the company,that does not encourage me to believe the company understands it.

when i 1st posted about it leaders here didnt even know what a ce was.
You should ask-why would people be opposed to warning the co????? Thats the real question.

The stock i was in that was transitioning from no info/limited info to otcqb was hit w a ce when pps rose because shorters called otc to fraudulently say there was promo-when there wasnt.

But otc broadly defines almost anything that causes significant pps increase to be a promo in a noncurrent co.

They and sec brokers etc believe any co which transitions to significant revenue while still no info is defrauding investors- thats THEIR belief/mindset.

thus to PROTECT the co/longs I've warned the co needs to upgrade to current BEFORE some event causes pps to rise significantly and thus get a ce now that they are transitioning to substantial revenues,

because otc etc are trying to force all co's to upgrade to current and thus have slapped a ce on thousands of companies over the years-last i knew there were maybe 500 ce co's.

longs lost 99% in that other ce because once a ce is imposed-almost always without warning ,brokers prohibit buying while shorting, and the co is put on sec etc radar/sanctions etc.

I sensed this would happen to NNLX unless they upgraded before the catalsyts we know are coming do raise pps enough to get a ce.
I've explained and posted from otc's own site the reasons why shorters target non-current co's.

So i'm explaining a SOLUTION to much of the shorter problem which will also protect the co from a ce and broker restrictions and sec sanctions etc.

SOLUTIONS are not negative-they are positive. If nnlx experiences a ce etc because they have not understood this, everybody will wish they had followed this advice.

Yet i've been vilified and STRONGLY hated and falsely accused by some for warning about this problem-which makes no sense.
A rational approach would be -thank you so much for warning about this -because we werent aware of this at all.

in the co i which i experienced this,longs blamed the company and mods and dd longs for NOT warning about this-and at that time many of these things were new -never before seen-so nobody could warn about this.

Longs blamed/threatened/hated the co and the mods and dd longs for NOT warning-it became a continuous blame game/cesspool of threats/hatred. I'm trying to PREVENT that from happening here. Thats a GOOD thing-a POSITIVE thing.

i dont control otc sec brokers or their beliefs. They dont allow co or 3rd parties to do ANYTHING that causes a large pps increase unless the co is current otc class.

Nanologix Inc (NNLX) Stock Research Links

NNLX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 9

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 17

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 15

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 7

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 7

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 9

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 12

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading

Top 5 Most Recently Viewed Articles

Upcoming Earnings Announcements and Market Insights

Updated Category News Views 249

Companies Reporting Earnings Before The Market Opens Various companies are preparing for their quarterly earnings reports, each with expectations that could impact their stock performance in the market. For example, Bank of Hawaii is anticipated to report quarterly earnings of $1.05 per share on revenue of approximately $174.39 million. Similarly, Business First...

Continue Reading
Bloom Nutrition Unveils Bloom Pop: A Healthier Soda Choice

Updated Category News Views 425

Bloom Nutrition Introduces Bloom Pop Bloom Nutrition, the brand known for revolutionizing the wellness industry, has launched an exciting new product called Bloom Pop. This innovative soda is now available exclusively at Walmart, marking a significant step in the brand's journey towards making healthier options fun and accessible. A Bold and Bubbly Innovation Bloom Pop...

Continue Reading
Renault Surpasses Stellantis in European Car Market Growth

Updated Category News Views 502

Renault's Growth in the European Car Market Recent statistics reveal that new car sales in Europe showed a modest increase of 0.9% in 2024, primarily driven by a significant rise in hybrid vehicle registrations. This surge marks the fourth consecutive month where hybrid sales have surpassed those of petrol vehicles, indicating a pivotal shift in consumer preferences....

Continue Reading
Market Reactions Following Intense Presidential Debate Showdown

Updated Category News Views 91

Markets React to the Presidential Debate U.S. stock futures slipped and the dollar softened as investors watched a heated presidential debate reshape the political conversation. It was the first direct face-off between Republican candidate Donald Trump and Democratic Vice President Kamala Harris. Early reads from traders and analysts suggested Harris may have had the...

Continue Reading
Eli Lilly's Kisunla Gains Approval for Alzheimer's Treatment in UK

Updated Category News Views 81

Eli Lilly's Kisunla Gains Approval for Alzheimer's Treatment in the UK Eli Lilly and Company has recently celebrated a significant milestone with the approval of their innovative treatment, Kisunla™ (donanemab-azbt), for mild cognitive impairment and mild dementia associated with Alzheimer's disease. This groundbreaking therapy is specifically designed for adult...

Continue Reading